|
|||||||||
|
HORIZONS PROJECT Very high levels of patient adherence are required for antiretroviral therapy (ART) to be effective and to prevent the emergence of resistant HIV strains. While antiretrovirals (ARVs) have been available in India since 1997, very little information is available on the levels of adherence to ART among people living with HIV and AIDS in India. In addition, optimism related to ART’s success in slowing disease progression, reducing viral load, and improving health status may lead to more risky sexual practices. To meet these knowledge gaps and better understand the sexual risk behavior of patients on ART, Horizons and research partners conducted a study to assess current levels of adherence to ART among a sample of people living with HIV and AIDS, identify factors that influence their adherence to treatment, and determine their sexual risk behaviors. Three hundred ten HIV-positive patients currently on ART and attending one private and three public-sector health facilities in Delhi and Pune were interviewed between May and August 2004, using a semi-structured questionnaire. Key findings include:
Location Pune and New Delhi, India Duration January 2004–June 2005 Horizons and Population Council researchers Non-Council collaborators Indrani Gupta (Institute of Economic Growth) Sanjay Pujari (Ruby Hall Clinic) A.K. Sengar, Amita Rawal (Northern Railway Hospital) Rajiv Garg (Employees' State Insurance Corporation) Sanjay Katke, Nilofer Shaikh, Sheetal Sorabia, Milli Barua, Sandeep Rasapulkar, Pauline Gomes, Mrudul Patil (consultants) Donors US Agency for International Development Publications/Resources 2008 2006 Related projects See Also
|
|